Background
==========

Respiratory tract infections (RTI) are common in adults and children worldwide. The disease varies in severity, presenting as uncomplicated, subacute, acute and chronic infection. RTIs can be life threatening depending on the causative agent and host condition. In children, a high incidence of RTI is caused either by: 1) heightened exposure of young children to RTI infectious agents from siblings, friends, and child care; 2) environmental factors; and 3) inherited disorders of the immune system \[[@B1]\]. In industrialized and developed countries, nearly 50% of pediatric consultations are RTI related \[[@B2],[@B3]\], and at least 1.9 million children died from acute RTI with 70% of them in Africa and Asia in 2000 \[[@B4]\].

There are a number of infectious agents that cause RTI. Bacteria, such as *Haemophilus influenzae*, *Streptococcus pneumoniae*, *Escherichia coli*, *Klebsiella pneumoniae*, *Mycoplasma pneumonia*, and *Chlamydia trachomatis*are among the most common. However, 80%-90% RTI are caused by viruses, such as respiratory syncytial virus (RSV), influenza virus, parainfluenza virus, and adenovirus (AdV) \[[@B1],[@B5]\]. RSV is one of the most common agents of RTI in infants and young children in many countries. It is estimated to cause \~39% of all pneumonia cases and up to 6% of pneumonia-associated deaths \[[@B6]\]. Parainfluenza virus and influenza virus also are commonly isolated viruses from children with viral RTI.

HAdV-associated RTI is reportedly low. It accounts for 4%-10% cases of pneumonia, 2%-10% cases of bronchiolitis, and 3%-9% cases of croup \[[@B7]\]. Severity of infection associated with HAdV varies with the different HAdV serotypes \[[@B7]-[@B9]\]. There are at least 51 immunologically distinct HAdV types classified into six species, designated A to F \[[@B10]\]. Viruses causing RTI are usually isolated in the laboratory from patients\' nasal secretions and serotyped by immunological typing methods \[[@B11]-[@B13]\]. In recent years, molecular identification of the virus has become more common, where distinction of the virus types can be made through specific genomic sequence amplification by polymerase chain reaction (PCR) and determination of the partial hexon gene sequence \[[@B14],[@B15]\]. Presently, there is no report of the prevalent HAdV types causing infections among Malaysians. This could be due to the low infection and fatality rates of the infection resulting in limited interest in typing the virus. The present study was undertaken to type HAdV of pediatric patients younger than 5 years seen at the University of Malaya Medical Center (UMMC), Kuala Lumpur, Malaysia.

Methods
=======

Virus
-----

Twenty-seven archived HAdV isolates were recovered from the UMMC virology repository and used for the study. The isolates were derived mainly from the nasopharyngeal secretions (NPS) of children younger than 5 years diagnosed with RTI (Table [1](#T1){ref-type="table"}). Virus isolation and propagation were performed using African green monkey kidney cells (Vero), human lung carcinoma cells (A549), and dog kidney cells (MDCK). The presence of HAdV was detected by immunofluorescence staining using specific antibodies (Cat. No. 5000; Light Diagnostics Inc., Salt Lake City, UT, USA) following manifestation of cytopathic effects. Virus inoculum was prepared and kept at -70°C until needed for genomic typing. Further maintenance and propagation of the HAdV isolates were performed in A549 cells.

###### 

Human adenoviruses isolated at the University of Malaya Medical Centre from 1999 to 2005.

  Sample     Year   Isolation site^a^   Age      Diagnosis                              Serotype
  ---------- ------ ------------------- -------- -------------------------------------- ----------
  AD01MY99   1999   NPS                 NA^b^    Pneumonia                              B3
                                                                                        
  AD02MY99   1999   NPS                 3 mth    Chronic lung diseases                  B7
                                                                                        
  AD04MY00   2000   RS                  7 mth    HFMD                                   F40
                                                                                        
  AD05MY00   2000   TS                  1 yr     HFMD                                   C2
                                                                                        
  AD06MY00   2000   TS                  8 mth    HFMD                                   C1
                                                                                        
  AD07MY01   2001   RS                  6 mth    Intestinal obstruction                 F41
                                                                                        
  AD08MY00   2000   RS                  NA       HFMD                                   C5
                                                                                        
  AD09MY01   2001   NPS                 I yr     Acute bronchiolitis                    C1
                                                                                        
  AD10MY01   2001   NPA                 1 yr     Bronchiolitis                          C2
                                                                                        
  AD11MY02   2002   NPS                 1 yr     Bronchopnuemonia, hypochronic anemia   C1
                                                                                        
  AD12MY02   2002   NPS                 1 yr     Bronchiolitis                          C1
                                                                                        
  AD13MY03   2003   NPS                 10 mth   Acute gastroenteritis                  C2
                                                                                        
  AD14MY03   2003   NPS                 1 yr     Viral fever                            C5
                                                                                        
  AD15MY03   2003   NPS                 8 mth    Acute bronchiolitis                    C2
                                                                                        
  AD16MY03   2003   NPS                 NA       Bronchopneumonia                       C2
                                                                                        
  AD17MY04   2004   NPS                 2 yr     Acute bronchiolitis                    C1
                                                                                        
  AD18MY04   2004   NPS                 9 mth    Pneumonia                              C5
                                                                                        
  AD19MY04   2004   NPS                 5 mth    Bronchiolitis                          B3
                                                                                        
  AD20MY04   2004   NPS                 2 yr     Pneumonia                              C2
                                                                                        
  AD21MY04   2004   NPS                 3 yr     Pneumonia                              C1
                                                                                        
  AD22MY04   2004   NPS                 1 yr     Bronchopneumonia                       C2
                                                                                        
  AD23MY04   2004   NPS                 5 mth    Bronchiolitis                          C6
                                                                                        
  AD24MY04   2004   NPS                 3 yr     Viral fever                            B3
                                                                                        
  AD25MY04   2004   NPS                 8 mth    Pulmonary collapse                     C5
                                                                                        
  AD26MY04   2004   NPS                 1 yr     Pneumonia                              B3
                                                                                        
  AD27MY04   2004   NPS                 3 mth    Acute bronchiolitis                    C2
                                                                                        
  AD28MY05   2005   NPS                 2 yr     Bronchopneumonia                       B3

^a^NPS is nasopharyngeal secretion; RS is rectal swab; TS is throat swab

^b^Not available

PCR amplification and genome sequencing
---------------------------------------

Viral genomic DNA was extracted using Tri Reagent^®^(Molecular Research Center Inc., Cincinnati, OH, USA) following the manufacturer\'s protocol. The partial hexon gene was amplified using the primer pair, AdTU7 (5\'-GCCACCTTCTTCCCCATGGC-3\') and AdTU4 (5\'-GTAGCGTTGCCGGCCGAGAA-3\') to amplify a 1,001 bp fragment of the partial hexon gene (position 20,733 - 21,734; Accession \# NC_001405). A nested polymerase chain reaction (PCR) also was performed on the amplified fragment using the primers, AdU-S (5\'-TTCCCCATGGCNCACAACAC-3\') and AdU-A (5\'-GCCTCGATGACGCCGCGGTG-3\') which resulted in a 956 bp fragment. Amplification was performed for 36 cycles consisting of a denaturation step at 94°C for 1 min, an annealing step at 50°C for 1 min, and an extension step at 72°C for 2 min. The extension was continued at 72°C for 7 min. The amplified DNA fragment was separated in 1.5% agarose gel (Promega, Madison, WI, USA), and purified using QIA Quick gel extraction system (Qiagen GmbH, Hilden, Germany) according to the manufacturer\'s protocol. The DNA fragments were sequenced at Macrogen Inc. (Seoul, Korea).

Sequence and phylogenetic analysis
----------------------------------

The partial hexon gene sequences were aligned and phylogenetic trees were drawn as previously described \[[@B16]\]. Briefly, the HAdV partial hexon gene sequences were analyzed using Sequencher 4.6 (Gene Codes Corporation, Ann Arbor, MI) and aligned against other available AdV sequences using ClustalX \[[@B17]\]. Phylogenetic trees were drawn using the maximum-likelihood method as implemented in PHYLIP 3.67 \[[@B18]\] and the maximum-parsimony method using MEGA4 \[[@B19]\]. Bootstrap values were obtained from a random sampling of 100 replicates. Reference HAdV sequences used to build the phylogenetic trees were obtained from the GenBank. Details on the reference sequences are shown in Table [2](#T2){ref-type="table"}.

###### 

Reference adenovirus (AdV) strains from the Genbank used for the typing of human AdV isolated at the University of Malaya Medical Centre.

  Accession Number                  Serotype   Country/Strain
  --------------------------------- ---------- -------------------------
  HAdV_A\_[NC_001460](NC_001460)    A12        ATCC
                                               
  HAdV_B\_[NC_004001](NC_004001)    B11        Slobitski
                                               
  HAdV_C\_[NC_001405](NC_001405)    C2         NA^a^
                                               
  HAdV_D\_[NC_002067](NC_002067)    D17        NA
                                               
  HAdV_E\_[NC_003266](NC_003266)    E4         Vaccine CL68578
                                               
  HAdV_F\_[NC_001454](NC_001454)    F40        Dugan
                                               
  HAdV_F\_[L19443](L19443)          F40        Dugan
                                               
  HAdV_3\_[AY878716](AY878716)      B3         Guangzhou, China
                                               
  HAdV_3\_[AF542108](AF542108)      B3         Korea
                                               
  HAdV_3\_[AF542129](AF542129)      B3         Korea
                                               
  HAdV_3\_[DQ086466](DQ086466)      B3         NA
                                               
  HAdV_7\_[AF053085](AF053085)      B7         S-1058; Japan
                                               
  HAdV_7\_[AY769945](AY769945)      B7         95-81; Korea
                                               
  HAdV_7\_[AF515814](AF515814)      B7         China
                                               
  HAdV_7\_[AC_000018](AC_000018)    B7         NA
                                               
  HAdV_7\_[AY769946](AY769946)      B7         Strain 99-95; Korea
                                               
  HAdV_7\_[AB243009](AB243009)      B7         Kyoto, Japan
                                               
  HAdV_11\_[AC_000015](AC_000015)   B11        NA
                                               
  HAdV_11\_[AF532578](AF532578)     B11        Slobitski
                                               
  HAdV_11\_[AY163756](AY163756)     B11        Ad11p Slobitski
                                               
  HAdV_14\_[AY803294](AY803294)     B14        De Wit/ATCC VR1091
                                               
  HAdV_14\_[DQ149612](DQ149612)     B14        NA
                                               
  HAdV_16\_[X74662](X74662)         B16        ATCC CH.79
                                               
  HAdV_21\_[AB053166](AB053166)     B21        AV-1645
                                               
  HAdV_34\_[AY737797](AY737797)     B34        Compton/ATCC VR716
                                               
  HAdV_34\_[AB052911](AB052911)     B34        NA
                                               
  HAdV_35\_[AC_000019](AC_000019)   B35        Old world monkey strain
                                               
  HAdV_35\_[AY128640](AY128640)     B35        Holden/ATCC VR718
                                               
  HAdV_35\_[AY271307](AY271307)     B35        35p
                                               
  HAdV_35\_[AB052912](AB052912)     B35        Japan
                                               
  HAdV_50\_[DQ149643](DQ149643)     B50        NA
                                               
  HAdV_50\_[AY737798](AY737798)     B50        Wan/ATCC VR1502
                                               
  HAdV_1\_[AC_000017](AC_000017)    C1         P1 C124G1
                                               
  HAdV_1\_[Y17244](Y17244)          C1         Ad71
                                               
  HAdV_2\_[AC_000007](AC_000007)    C2         NA
                                               
  HAdV_2\_[AY224392](AY224392)      C2         Korea
                                               
  HAdV_2\_[AF542118](AF542118)      C2         Korea
                                               
  HAdV_2\_[AJ293905](AJ293905)      C2         Germany
                                               
  HAdV_2\_[AJ293901](AJ293901)      C2         United Kingdom
                                               
  HAdV_5\_[AF542130](AF542130)      C5         Korea
                                               
  HAdV_5\_[AF542128](AF542128)      C5         Korea
                                               
  HAdV_5\_[AF542124](AF542124)      C5         Korea
                                               
  HAdV_5\_[AC_000008](AC_000008)    C5         NA
                                               
  HAdV_5\_[AF542109](AF542109)      C5         Korea
                                               
  HAdV_6\_[DQ149613](DQ149613)      C6         NA
                                               
  HAdV_6\_[Y17245](Y17245)          C6         Ton66
                                               
  HAdV_40\_[X51782](X51782)         F40        Dugan
                                               
  HAdV_41\_[X51783](X51783)         F41        Tak
                                               
  HAdV_41\_[D13781](D13781)         F41        Tak

^a^Not Available

The study was approved by the University Malaya Medical Centre Ethics Committee (Approval \#794.6).

Results
=======

A total of 2,583 pediatric patients with RTI were treated at the UMMC from 1999 to 2005. Of these patients, 48 (\<2%) were positive for HAdV by either direct immunofluorescence staining of the patient\'s NPS, PCR amplification, or virus isolation. HAdV also was isolated from the throats of patients with HFMD. These HFMD patients usually did not present with RTI symptoms, but throat swabs were routinely collected in addition to rectal swabs.

In the present study, the partial hexon gene sequences (nucleotide 20,734-21,737) of 27 HAdV isolates from UMMC were determined. The sequences were aligned and phylogenetic trees were drawn using the maximum-likelihood and maximum-parsimony methods. Only results from the maximum-likelihood method were presented, as trees drawn from both the methods were similar. The nucleotide sequence alignment clustered the UMMC isolates into HAdV-C species (n = 19), HAdV-B species (n = 6), and HAdV-F species (n = 2) with high bootstrap values. Within the HAdV-C species, eight isolates were HAdV-2 (42%); six isolates, HAdV-1 (32%); four isolates, HAdV-5 (21%);, and one isolate, HAdV-6 (5%; Figure [1a](#F1){ref-type="fig"}). When compared with other HAdV from the GenBank, most of the UMMC HAdV-5 and HAdV-2 isolates formed a separate subcluster of their own (Figure [1a](#F1){ref-type="fig"}). Within HAdV-B species, five isolates grouped into HAdV-3, and one was HAdV-7 (Figure [1b](#F1){ref-type="fig"}). HAdV-3 isolates from the study formed a separate subcluster together with an isolate from Guangzhou, China (Accession \# [AY878716](AY878716)) distinct from other known HAdV-3. This raised the possibility that the viruses may share a common ancestral lineage with the Malaysian isolate that was isolated in 1999. The HAdV-7 clustered together with isolates from the East Asian countries suggesting a possible widespread presence of the virus in the East Asian region. Four of the HAdV isolates sequenced in the study were from HFMD patients, and three of them clustered together with the HAdV-C species. One isolate clustered with known HAdV-40, whereas an isolate from the rectal swab of a patient diagnosed with intestinal obstruction clustered with known HAdV-41. No HAdV-B genotype previously associated with fatal cases of HFMD \[[@B20],[@B21]\] was detected in any of the HFMD patient samples. Isolates from HFMD patients were included in the study initially because no effort was made to discriminate the samples from those strictly with RTI. Patients with HFMD normally would not present with RTI symptoms.

![**Molecular typing of human adenoviruses (HAdV) isolated at the University of Malaya Medical Center (UMMC) from 1999 to 2005**. HAdV-1 and HAdV-2 comprised most of the HAdV-C species isolated at the UMMC (a). HAdV-B species consisted of HAdV-3 and HAdV-7. HAdV-3 formed its own distinct cluster separate from the rest of the group (b). Two isolates from the study were grouped as HAdV-F serotype 40 and 41 (c), commonly implicated in gastroenteritis.](1471-2431-10-46-1){#F1}

Discussion
==========

Human adenovirus is most commonly associated with respiratory illnesses. However, depending on the infecting serotype, the virus also causes various other illnesses, including gastroenteritis, conjunctivitis, cystitis, and non- specific exanthemas \[[@B13],[@B22]\]. Symptoms of the respiratory illness associated with HAdV range from mild infection to severe pneumonia \[[@B8],[@B23]\]. Young children and immunocompromised patients are especially vulnerable to severe complications of HAdV infection \[[@B24],[@B25]\]. The findings that less that 2% of UMMC pediatric RTI is associated with HAdV respiratory infection is consistent with other reports that HAdV-associated respiratory infection is usually low in comparison to other viruses, such as RSV and parainfluenza virus. The infection also is generally milder and rarely leads to severe complications and deaths \[[@B8],[@B26]\]. The low number of HAdV isolation among pediatric patients seen at the UMMC also suggests that the virus is not associated with any major RTI outbreaks during the period from 1999 to 2005. This is perhaps among the reasons why there have not been many efforts to identify the HAdV species and types in children with RTI in many countries, including Malaysia. In addition, the low incidence of RTI caused by HAdV in the community hampered the effort to get enough representative isolates.

In our study, HAdV partial hexon gene sequences were used to type the different HAdV isolates. This gene region contains the hypervariable region that confers HAdV serotype specificity. Using this molecular typing method, HAdV-C species, specifically type 1 and 2, were the most common HAdV isolated from the pediatric patients seen at UMMC from 1999 to 2005. In contrast, studies done in the United States of America, United Kingdom, Korea, and China, showed HAdV-B species as the most commonly isolated HAdV \[[@B27]-[@B30]\]. The reasons for the marked differences are not known. It could be that HAdV-C is more common in the region in comparison to the more developed countries. However, the prevalence of HAdV-C species in the neighboring countries could not be compared because information from these countries are lacking.

Overrepresentation of HAdV-C in UMMC pediatric patients could suggest a high prevalence of the virus in the community. There are reports that the virus could persist and cause asymptomatic latent infection in rabbits for as long as one year \[[@B31]\]. HAdV-C serotypes 1, 2, and 5 are the most common serotype of HAdV associated in latent infection of tonsils and adenoids of humans, which at times cause RTI in young children \[[@B32]\]. The prolonged presence of the virus in infected children increases its transmissibility, and this could contribute to the persistence of the virus of young children in Malaysia. The ubiquitous presence of the virus also could help explain isolation of the virus from patients with HFMD and nonspecific viral fever. On the other hand, the results also could reflect the higher tendency of children with HAdV-C species infection to seek medical attention, hence suggesting that the virus could cause more severe manifestations of RTI. Further studies, however, will be needed to verify this.

Conclusions
===========

The present study is the first to report the prevalent and circulating HAdV types in Malaysia. It showed that HAdV-C species especially HAdV-1 and HAdV-2 were the most commonly isolated HAdV among pediatric patients seen at UMMC from 1999 to 2005, followed by HAdV-B species type 3. These viruses are common serotypes of HAdV causing acute RTI in pediatric patients. Because no such study has ever been reported in Malaysia, the present study provides a benchmark for future studies of HAdV infection in the country.
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